Innovent Biologics, Inc. (OTCMKTS:IVBXF – Get Free Report)’s share price traded down 1.7% during trading on Monday . The stock traded as low as $10.55 and last traded at $10.55. 1,609 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 33,650 shares. The stock had previously closed at $10.73.
Innovent Biologics Price Performance
The business’s 50 day moving average is $11.40 and its 200 day moving average is $11.50.
About Innovent Biologics
Innovent Biologics, Inc, a biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People's Republic of China. It offers Tyvyt, a human anti-PD-1 monoclonal antibody; BYVASDA, a fully-human anti-VEGF monoclonal antibody; HALPRYZA, a recombinant chimeric murine/human anti-CD20 monoclonal antibody; SULINNO, a fully-human antiTNF-a monoclonal antibody; Pemazyre, a selective FGFR inhibitor; Olverembatinib, a novel BCR-ABL TK; Cyramza, a VEGF receptor 2 antagonist; and Retsevmo, a selective and potent RET kinase inhibitor.
Featured Stories
- Five stocks we like better than Innovent Biologics
- What Investors Need to Know to Beat the Market
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Why Invest in 5G? How to Invest in 5G Stocks
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Innovent Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovent Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
